Document is current
Any future updates will be listed below
-
Authors
Mavrakanas, Thomas A.
Tsoukas, Michael A.
Brophy, James M.
Sharma, Abhinav
Gariani, Karim
-
Funding
Funding for this research was provided by:
the Fonds de Recherche Santé Quebec
Quebec Society of Nephrology
Alberta Innovates Health Solution
European Society of Cardiology young investigator grant
- License Information
-
More Information
Article History
Received: 10 May 2023
Accepted: 17 September 2023
First Online: 23 September 2023
Competing interests
: Dr. Mavrakanas received speaker honoraria from Daiichi Sankyo, BMS Canada, Janssen, Astra Zeneca, and Pfizer and has served on advisory boards for Boehringer Ingelheim, Bayer, GSK, and Servier outside the submitted work. He has also received an unrestricted research grant from Astra Zeneca. Dr. Tsoukas received speaker honoraria from NovoNordisk, Boehringer-Ingelheim, Janssen, Eli Lilly, and AstraZeneca outside the submitted work. Dr. Sharma received research and personal support from Roche Diagnostics, Boehringer-Ingelheim, Servier, Novartis, AstraZeneca, Janssen, Novo-Nordisk, BMS-Pfizer, and Takeda. The remaining authors have nothing to disclose.
